Isoflavones modulate the glucuronidation of estradiol in human liver microsomes

Carcinogenesis

Volumn 26, Issue 12, 2005, Pages 2172-2178

  Pfeiffer, Erika ^a   Treiling, Christian R ^a   Hoehle, Simone I ^a   Metzler, Manfred ^a  

^a UNIVERSITY OF KARLSRUHE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3' HYDROXYDAIDZEIN; 6 HYDROXYDAIDZEIN; BIOCHANIN A; DAIDZEIN; EQUOL; ESTRADIOL; ESTRADIOL 17 GLUCURONIDE; ESTRONE GLUCURONIDE; ETHINYLESTRADIOL; FORMONONETIN; GENISTEIN; GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 2B7; GLYCITEIN; ISOENZYME; ISOFLAVONE DERIVATIVE; UNCLASSIFIED DRUG;

ALLOSTERISM; ANTINEOPLASTIC ACTIVITY; ARTICLE; CLEARANCE; CONTROLLED STUDY; ENZYME KINETICS; GLUCURONIDATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER MICROSOME; MICHAELIS MENTEN KINETICS; PRIORITY JOURNAL; PROTEIN FUNCTION;

ALLOSTERIC REGULATION; ANTINEOPLASTIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ESTRADIOL; GENISTEIN; GLUCURONIDES; GLUCURONOSYLTRANSFERASE; HUMANS; ISOFLAVONES; KINETICS; MICROSOMES, LIVER; PHYTOESTROGENS; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY;

EID: 27944483765     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgi197     Document Type: Article

References (38)

1. Henderson,B.E., Ross,R.K., Pike,M.C. and Casagrande,J.T. (1982) Endogenous hormones as a major factor in human cancer. Cancer Res., 42, 3232-3239.
2. Kelsey,J.L. and Whittemore,A.S. (1994) Epidemiology and primary prevention of cancers of the breast, endometrium, and ovary. A brief overview. Ann. Epidemiol., 4, 89-95.
3. Bernstein,L. and Ross,R.K. (1993) Endogenous hormones and breast cancer risk. Epidemiol. Rev., 15, 48-65.
4. Thomas,H.V., Reeves,G.K. and Key,T.J. (1997) Endogenous estrogen and postmenopausal breast cancer: A quantitative review. Cancer Causes Control, 8, 922-928.
5. Rose,D.P., Boyar,A.P. and Wynder,E.L. (1986) International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer, 58, 2363-2371.
6. Cancer facts and figures. (1994) Atlanta: American Cancer Society.
7. Messina,M.J. (1999) Legumes and soybeans: Overview of their nutritional profiles and health effects. Am. J. Clin. Nutr., 70, 439S-450S.
8. Limer,J.L. and Speirs,V. (2004) Phyto-oestrogens and breast cancer chemoprevention. Breast Cancer Res., 6, 119-127.
9. Adlercreutz,H. (2002) Phytoestrogens and breast cancer. J. Steroid Biochem. Mol. Biol., 83, 113-118.
10. Barnes,S. (1998) Evolution of the health benefits of soy isoflavones. Proc. Soc. Exp. Biol. Med., 217, 386-392.
11. Setchell,K.D. (1998) Phytoestrogens: The biochemistry, physiology, and implications for human health of soy isoflavones. Am. J. Clin. Nutr., 68, 1333S-1346S.
12. Adlercreutz,H. (1995) Phytoestrogens: Epidemiology and a possible role in cancer protection. Environ. Health Perspect., 103 (Suppl. 7), 103-112.
13. Kirk,C.J., Harris,R.M., Wood,D.M., Waring,R.H. and Hughes,P.J. (2001) Do dietary phytoestrogens influence susceptibility to hormone-dependent cancer by disrupting the metabolism of endogenous oestrogens? Biochem. Soc. Trans., 29, 209-216.
14. Ritter,J.K. (2000) Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions. Chem. Biol. Interact., 129, 171-193.
15. Senafi,S.B., Clarke,D.J. and Burchell,B. (1994) Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation. Biochem. J., 303, 233-240.
16. Fisher,M.B., Campanale,K., Ackermann,B.L., VandenBranden,M. and Wrighton,S.A. (2000) In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin. Drug Metab. Dispos., 28, 560-566.
17. Gall,W.E., Zawada,G., Mojarrabi,B., Tephly,T.R., Green,M.D., Coffman,B.L., Mackenzie,P.I. and Radominska-Pandya,A. (1999) Differential glucuronidation of bile acids, androgens and estrogens by human UGT1A3 and 2B7. J. Steroid Biochem. Mol. Biol., 70, 101-108.
18. Houston,J.B. and Kenworthy,K.E. (2000) In vitro-in vivo scaling of CYP kinetic data not consistent with the classical Michaelis-Menten model. Drug Metab. Dispos., 28, 246-254.
19. Vore,M., Liu,Y. and Huang,L. (1997) Cholestatic properties and hepatic transport of steroid glucuronides. Drug Metab. Rev., 29, 183-203.
20. Lake,B.G. (1987) Preparation and characterization of microsomal fractions for studies on xenobiotic metabolism. In Snell,K. and Mullock,B. (eds), Biochemical Toxicology. IRL Press, Oxford, pp. 183-215.
21. Bradford,M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
22. Matern,H., Heinemann,H. and Matern,S. (1994) Radioassay of UDP-glucuronosyltransferase activities toward endogenous substrates using labeled UDP-glucuronic acid and an organic solvent extraction procedure. Anal. Biochem., 219, 182-188.
23. Telang,N.T., Suto,A., Wong,G.Y., Osborne,M.P. and Bradlow,H.L. (1992) Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. J. Natl Cancer Inst., 84, 634-638.
24. Cavalieri,E., Frenkel,K., Liehr,J.G., Rogan,E. and Roy,D. (2000) Estrogens as endogenous genotoxic agents-DNA adducts and mutations. J. Natl Cancer Inst. Monogr., 75-93.
25. Guillemette,C., Belanger,A. and Lepine,J. (2004) Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: An overview. Breast Cancer Res., 6, 246-254.
26. Williams,J.A., Ring,B.J., Cantrell,V.E., Campanale,K., Jones,D.R., Hall,S.D. and Wrighton,S.A. (2002) Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes. Drug Metab. Dispos., 30, 1266-1273.
27. King,C.D., Green,M.D., Rios,G.R., Coffman,B.L., Owens,I.S., Bishop,W.P. and Tephly,T.R. (1996) The glucuronidation of exogenous and endogenous compounds by stably expressed rat and human UDP-glucuronosyltransferase 1.1. Arch. Biochem. Biophys., 332, 92-100.
28. Alkharfy,K.M. and Frye,R.F. (2002) Sensitive liquid chromatographic method using fluorescence detection for the determination of estradiol 3- and 17-glucuronides in rat and human liver microsomal incubations: formation kinetics. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 774, 33-38.
29. Hutzler,J.M. and Tracy,T.S. (2002) Atypical kinetic profiles in drug metabolism reactions. Drug Metab. Dispos., 30, 355-362.
30. Tang,W., Stearns,R.A., Wang,R.W., Chiu,S.H. and Baillie,T.A. (1999) Roles of human hepatic cytochrome P450s 2C9 and 3A4 in the metabolic activation of diclofenac. Chem. Res. Toxicol., 12, 192-199.
31. Tang,W., Stearns,R.A., Kwei,G.Y. et al. (1999) Interaction of diclofenac and quinidine in monkeys: Stimulation of diclofenac metabolism. J. Pharmacol. Exp. Ther., 291, 1068-1074.
32. Lu,L.J., Anderson,K.E., Grady,J.J. and Nagamani,M. (1996) Effects of soya consumption for one month on steroid hormones in premenopausal women: Implications for breast cancer risk reduction. Cancer Epidemiol. Biomarkers Prev., 5, 63-70.
33. Lepine,J., Bernard,O., Plante,M., Tetu,B., Pelletier,G., Labrie,F., Belanger,A. and Guillemette,C. (2004) Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human uridine diphospho-glucuronosyl-transferases expressed in endometrium. J. Clin. Endocrinol. Metab., 89, 5222-5232.
34. Kulling,S.E., Lehmann,L. and Metzler,M. (2002) Oxidative metabolism and genotoxic potential of major isoflavone phytoestrogens. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 777, 211-218.
35. Bayer,T., Colnot,T. and Dekant,W. (2001) Disposition and biotransformation of the estrogenic isoflavone daidzein in rats. Toxicol. Sci., 62, 205-211.
36. Kulling,S.E., Rosenberg,B., Jacobs,E. and Metzler,M. (1999) The phytoestrogens coumoestrol and genistein induce structural chromosomal aberrations in cultured human peripheral blood lymphocytes. Arch. Toxicol., 73, 50-54.
37. Hsieh,C.Y., Santell,R.C., Haslam,S.Z. and Helferich,W.G. (1998) Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res., 58, 3833-3838.
38. Constantinou,A.I., White,B.E., Tonetti,D., Yang,Y., Liang,W., Li,W. and van Breemen,R.B. (2005) The soy isoflavone daidzein improves the capacity of tamoxifen to prevent mammary tumours. Eur. J. Cancer, 41, 647-654.